Loading
NASDAQConsumer DefensiveTobacco
Latest quote
$0.8707
−$0.0208 · -2.33%
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
Previous close
$0.8707
−$0.0208 · -2.33%
After-hours
$0.8881
+$0.0174 · +2.00%
Oct 8, 6:48 PM ET
Regular session · ET · Market data may be delayed.
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
Day range
Current $0.8707
52-week range
Current $0.8707
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
26
Expensive
Sentiment
40
Bearish
Risk
69
High Risk
Momentum
21
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
Day range
Current $0.8707
52-week range
Current $0.8707
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.05M USD | 11.88M USD | 32.2M USD | 40.5M USD | 30.95M USD |
| Cost of goods sold | 10.19M USD | 14.28M USD | 40.9M USD | 38.65M USD | 29.46M USD |
| Gross profit | −3.14M USD | −2.4M USD | −8.7M USD | 1.85M USD | 1.49M USD |
| Research and development | 688K USD | 1.13M USD | 2.64M USD | 3.58M USD | 3.91M USD |
| Selling, general, and administrative | 7.59M USD | 10.29M USD | 31.83M USD | 32.23M USD | 25.91M USD |
| Operating expenses | 8.28M USD | 11.55M USD | 36.24M USD | 35.48M USD | 29.9M USD |
| Interest income | 83K USD | 72K USD | 219K USD | 313K USD | 321K USD |
| Interest expense | 1.46M USD | 2.09M USD | 9.37M USD | 55K USD | 58K USD |
| Depreciation and amortization | 1.16M USD | 1.26M USD | 4.86M USD | 3.59M USD | 1.54M USD |
| Operating income | −11.42M USD | −13.95M USD | −44.93M USD | −33.64M USD | −28.41M USD |
| Net income | −5.05M USD | −15.16M USD | −140.78M USD | −59.8M USD | −32.61M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$1,237.5
142027.02% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 12, 2026 | 1:20 | — | — |
Stock split | Jan 26, 2026 | 1:15 | — | — |
Stock split | Jun 20, 2025 | 1:23 | — | — |
Stock split | Dec 17, 2024 | 1:135 | — | — |
Stock split | Apr 2, 2024 | 1:16 | — | — |
Stock split | Jul 5, 2023 | 1:15 | — | — |
Effective Jun 12, 2026
1:20
Effective Jan 26, 2026
1:15
Effective Jun 20, 2025
1:23
Effective Dec 17, 2024
1:135
Effective Apr 2, 2024
1:16
Effective Jul 5, 2023
1:15
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
